UK vaccine chief to step down at year-end as per her six-month contract, Hancock says
The head of Britain’s COVID-19 vaccine taskforce will step down at the end of the year and her departure is not related to criticism over a 670,000 pound ($881,000) public relations bill, the health minister said.
For more coronavirus news, visit our dedicated page.
Health Secretary Matt Hancock said Kate Bingham had always been due to leave at the end of the year after accepting a six-month contract.
For all the latest headlines follow our Google News channel online or via the app
Bingham, who normally leads biotech investments, has been criticized after the Sunday Times reported that she used eight full-time consultants from London PR agency Admiral Associates to oversee her media strategy.
Read more:
Coronavirus vaccine will be optional: UK health minister
Coronavirus: UK’s Johnson says still too early to rely on COVID-19 vaccine
Coronavirus: UK expects to receive 10 mln doses of Pfizer COVID-19 vaccine in 2020
“It was always a six month job and she was always clear that she couldn’t do it for longer than that,” Hancock told Times Radio.
Bingham, who was appointed chair of the taskforce on May 16, was not immediately available for comment.
Under Bingham’s leadership, the taskforce has secured supply deals for more than 350 million doses of six different COVID-19 vaccine candidates, including the Pfizer shot which is leading the race following positive trial data.
-
Coronavirus vaccine will be optional: UK health minister
People in Britain will be able to decide whether they want to have the coronavirus vaccine or not, health minister Matt Hancock said on Tuesday, ... Coronavirus -
Coronavirus: UK’s Johnson says still too early to rely on COVID-19 vaccine
Prime Minister Boris Johnson said Britain was ready to roll out a mass COVID-19 vaccination program but it was too early to rely on a vaccine as a ... Coronavirus -
Coronavirus: UK expects to receive 10 mln doses of Pfizer COVID-19 vaccine in 2020
Britain expects to have 10 million doses of Pfizer/BioNTech's candidate COVID-19 vaccine available by the end of the year if regulators approve it, ... Coronavirus -
Coronavirus: Delivery timetable for Oxford/AstraZeneca vaccine for UK pushed back
The timetable for delivery of the Oxford University/AstraZeneca COVID-19 vaccine candidate has slipped, the UK’s vaccine chief said, adding Britain ... Coronavirus -
Coronavirus: UK starts accelerated review for AstraZeneca’s COVID-19 vaccine
AstraZeneca said on Sunday Britain’s health regulator had started an accelerated review of its potential coronavirus vaccine.“We confirm the MHRA’s ... Coronavirus -
Coronavirus: UK vaccine chief targets spring rollout, but impact may be limited
The woman in charge of procuring possible COVID-19 vaccines for Britain said that rollout of the earliest shots could start this year, though their ... Coronavirus -
UK backs studies with $44 mln fund to accelerate vaccine development
Britain said on Tuesday it would back human challenge studies to accelerate the development of COVID-19 vaccines by exposing volunteers to the virus ... Coronavirus -
Coronavirus: UK’s spies defending COVID-19 vaccine work, MI5 chief says
British spies are trying to defend COVID-19 vaccine work against hostile powers that seek to either steal or sabotage research data in the race for ... Coronavirus -
Coronavirus: AstraZeneca resumes COVID-19 vaccine trial after UK green light
British clinical trials for the AstraZeneca and Oxford University coronavirus vaccine have resumed following confirmation by the Medicines Health ... Coronavirus -
Coronavirus: UK study tests if tuberculosis vaccine protects against COVID-19
The widely used BCG tuberculosis vaccine will be tested on frontline care workers in Britain for its effectiveness against COVID-19, researchers ... Coronavirus